Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ARCTURUS THERAPEUTICS HOLDINGS INC.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT)
Listen to this Section


$7.02
+0.0110 ( +0.16% ) 48.1K

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Market Data


Open $7.02
Previous Close $7.01
Volume 48.1K
Market Cap $199.25M
Day Range $6.92 - $7.45
52 Week Range $5.85 - $24.17
Shares Outstanding 28.42M
Change % +0.16%
Net Change ▲ 0.0110
Insider Ownership -0.04%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2013
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -31,310.00

Date Type Amount Purchased Purchaser
2025-08-19 Buy 1238.00 SASSINE ANDY
2025-08-19 Buy 1238.00 SASSINE ANDY
2024-06-21 Sale -15000.00 Slaoui Moncef
2024-06-18 Sale -3131.00 FARRELL PETER C
2024-06-18 Sale -3131.00 BARLOW JAMES F
2024-06-18 Sale -3131.00 Marquet Magda
2024-06-18 Sale -3131.00 Markels John
2024-06-18 Sale -3131.00 HOLMES EDWARD W
2024-06-18 Sale -3131.00 Marantz Jing L.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 59 Nov 12, 2025
nt Quarterly Reports 1 Nov 12, 2025
8-k 8K-related 13 Nov 10, 2025
8-k 8K-related 24 Oct 22, 2025
8-k 8K-related 15 Sep 26, 2025
8-k 8K-related 14 Aug 29, 2025
4/a Other 1 Aug 20, 2025
4 Insider transactions 1 Aug 19, 2025
10-q Quarterly Reports 58 Aug 11, 2025
8-k 8K-related 13 Aug 11, 2025

Latest News